L

Liom

www.liom.com link_icon

Liom Health AG Market Research Report





Company Overview



  • Name: Liom Health AG

  • Mission: No information is available

  • Founded: No information is available

  • Founders: No information is available

  • Key People:

  • Leo Grünstein, Founder & CEO

  • Bernd Wittner, PhD, Chief Technology Officer

  • Adler Perotte, MD, Chief Science & Innovation Officer

  • Ismene Grohmann, Chief Product Officer

  • Daniel Perotti, Chief Operating Officer

  • Jennifer Ireland, MD, Chief Financial Officer

  • Övünç Okyay, Co-founder & Venture Builder

  • Headquarters: Talstrasse 35, 8808 Pfäffikon SZ, Switzerland

  • Number of Employees: No information is available

  • Revenue: No information is available

  • Known For: Pioneering non-invasive glucose monitoring technology seamlessly integrated into health metrics wearables.


Products



  • Overview:

Liom Health AG is at the forefront of developing a revolutionary, non-invasive wearable device that integrates various health metrics.

Product Details



  • Non-Invasive Glucose Monitoring Wearable:

  • Description: A groundbreaking wearable device providing real-time insights into multiple health metrics.

  • Key Features:

  • Metabolic Monitoring: Continuous glucose monitoring, predictive alerts, meal optimization, time-in-range, and metabolic responsiveness.

  • Fitness Tracking: Metabolic burn, activity tracking and optimization, heart rate zones.

  • Cardiovascular Monitoring: Heart rate monitoring, variability, respiratory rate, cardiovascular flexibility.

  • Sleep Analysis: Sleep quality analysis, duration and stages tracking.

  • Mental Health Monitoring: Focus, energy, mental balance, stress factors, and monitoring metabolic contributors.

  • Unique Selling Proposition: Precise glucose measurements without skin piercing — a world-first in the realm of non-invasive technology.


Recent Developments



  • Recent Developments:

  • 31.07.2024: Liom rebrands from Spiden, signaling a strategic focus on advancing wearable health technology.

  • 05.01.2024: Announced a breakthrough in non-invasive glucose monitoring technology alongside key executive hires, supported by $15 million in new funding.

  • 04.09.2023: CEO Leo Grünstein discusses Liom’s innovative approach in developing advanced wearables capable of non-invasively measuring multiple biomarkers.

  • 18.08.2023: Focus on creating a wrist-worn device that measures glucose levels without needle pricking, aimed at boosting diabetic care.

  • Product Launches: No new specific product launches reported.

  • New Features: No information is available on newly added features to existing products.

  • Partnerships: No information is available on new partnerships.


Conclusion



Liom Health AG is playing a pioneering role in the MedTech industry, focusing on non-invasive glucose monitoring with their innovative wearable devices. Key recent developments and strategic initiatives reinforce their position as an industry disruptor aiming to simplify and deepen health metrics monitoring for users.